US payment policy for medications to treat opioid use disorder: landscape and opportunities, in Health Affairs Scholar
key takeaway: "The experts interviewed cautioned against rigid reimbursement models that force patients into one-size-fits-all care and endorsed future development and adoption of value-based MOUD payment models. More than 70% of experts surveyed reported that Medicare, Medicaid, and private insurers should increase payment for office- and opioid treatment program–based MOUD. Validation of MOUD performance metrics is needed to support future value-based initiatives."
Perinatal Mood And Anxiety Disorders Rose Among Privately Insured People, 2008–20, in Health Affairs
key takeaway: "Nationwide, perinatal mood and anxiety disorder (PMAD) diagnoses among privately insured people increased by 93.3 percent from 2008 to 2020, growing faster in 2015–20 than in 2008–14. Most states and demographic subgroups experienced increases, suggesting worsening morbidity in maternal mental health nationwide. PMAD-associated suicidality and psychotherapy rates also increased nationwide from 2008 to 2020. Relative to 2008–14, psychotherapy rates continued to rise in 2015–20, whereas suicidality rates declined."